Q1 2026 M&A Outlook: Australasian Brokerage Trends & Deal Flow

The Q1 2026 market in three headlines

Sentiment has shifted from the panic of 2024–2025 to cautious interest. Large PE firms are re-engaging, but they're being selective about where they deploy capital. Trade buyers are outpacing strategic acquirers in deal counts — they're moving faster and with fewer contingencies. Vendors have finally adjusted expectations: the 7–8x multiples of the 2021–2022 peak are gone for good, but well-run businesses are holding steady at 5x EBITDA and above. The market is functionally two-tiered now. Businesses with systems, recurring revenue, and clear growth are attracting multiple bidders and competitive tension. Everything else is taking longer to sell, and some sellers are wisely stepping back to improve operations before re-launching.

Deal flow trends: AU vs NZ 2024–2026

Where capital is actually flowing — sector by sector

**Healthcare services**: The strongest sector. Medical clinics, allied health networks, and diagnostic businesses are attracting PE firms and strategic buyers alike. Tailwinds are structural — aging population, chronic disease prevalence, and government healthcare funding all point upward. Well-managed networks with systems in place and clear geographic roll-up opportunities are trading at 5.5–7x EBITDA (per Mergermarket Q1 2026 report). Single-location practices or founder-dependent clinics pull 4–5.5x. **Supply chain and logistics**: Selective interest. Fleet operators and warehouse businesses with recurring contracts and documented systems are seeing PE activity at 4.5–6x EBITDA. Generic courier or freight brokerage is stalled — thin margins and high competition. **Professional services**: Two-speed market. Tax practices, compliance-focused accounting, and niche legal (IP, employment) are moving at 4.5–6x EBITDA. Generalist firms and rainmaker-dependent partnerships are stuck; multiples have fallen to 3–4x and buyer interest is thin. **SaaS and software**: Bifurcated. Early-stage, pre-revenue SaaS is nearly unfundable. Mature SaaS ($1M+ ARR, 70%+ gross margins, documented growth) is attracting PE at 5–7x revenue multiples or 6–8x EBITDA. **Hospitality and leisure**: Still the walking wounded. Multiples remain depressed at 3–4x EBITDA, and capital only moves if there's a clear operational turnaround or new management thesis. **Retail and franchises**: Weak. Consumer spending remains cautious in AU and NZ, and franchise valuations reflect this weakness. Few PE buyers are active here.

Q1 2026 sector activity snapshot

Exit multiples reality: what your business will actually sell for

**Premium tier (7–8x EBITDA)**: Recurring revenue, 70%+ gross margins, systems-driven operations, proven management layer below founder, and documented growth levers. Think: niche SaaS, multi-clinic dental/medical networks, or specialist logistics with long-term contracts. These are the businesses attracting competitive bidding. **Upper-mid tier (5.5–6.5x EBITDA)**: Growing revenue (15%+), solid margins, some management depth, and defensible positioning. This is where most 'good' businesses land — stable, scalable, but not exceptional. **Mid tier (4.5–5.5x EBITDA)**: Stable or slightly growing revenue, decent margins, but founder-dependent operations. Requires a credible improvement narrative to justify the multiple. **Lower tier (3–4.5x EBITDA)**: Distressed businesses, declining revenue, or highly cyclical. Only strategic buyers (seeking cost synergies or market consolidation) engage at these multiples. **NZ-specific adjustments**: Add 0.5–1x to AU comps for NZ businesses with strong local teams, market access, and minimal integration risk. These are real — NZ expertise and existing relationships carry valuation premium. Subtract 0.5x if there's single-currency risk or if your buyer is AU-based and unfamiliar with NZ regulatory/market dynamics.

Deal size distribution: where is the real activity?

Deal velocity: how fast will your business actually sell?

**Fast movers (under 6 months)**: Healthcare networks, niche SaaS with $1M+ ARR, specialist logistics with recurring contracts, and high-growth businesses (20%+ YoY). These attract 2–4 competing bidders and create tension that shortens process and improves valuation. **Normal pace (6–12 months)**: Well-managed mid-tier stable businesses, professional services with recurring revenue, and niche distribution plays. Usually sees 1–2 qualified buyers; process takes longer but still reaches a reasonable outcome. **Stalled (>12 months or withdrawn)**: Founder-dependent service businesses without clear management succession, businesses with declining revenue, commoditised sectors with razor-thin margins, and anything with regulatory uncertainty or single-customer concentration (30%+ of revenue). These either don't sell, or sell at steep discounts only to strategic buyers seeking cost synergies.

How deals are being structured right now

**Earn-outs are the new normal**. Most 2026 deals split consideration into two parts: base price (paid at close) plus performance-linked earn-out (typically 24 months). Many structures now offer 70% at close, 30% deferred to earn-out. The trade-off: sellers who accept this earn-out structure often get 0.5–1x EBITDA higher base price. If you're selling for 5x and accepting a 25% earn-out, your base might be 4.5x plus 1.5x EBITDA deferred. **Seller debt (seller notes)** are less common but used strategically for high-growth businesses. Some deals include 4–5% interest rate seller notes that help smooth buyer cash flow and show seller confidence in the business. **Owner transition requirements** are increasingly standard with PE buyers. Expect 12–24 months where you're contractually required to remain involved — board role, customer introductions, operational guidance. This protects the buyer against key-person risk and helps retain customers. Negotiate this carefully; longer transitions increase your deal risk if the business underperforms.

Market gaps: where sellers face headwinds

**NZ lower-mid-market is undersupplied with capital**: Businesses in the NZD 1–3M EBITDA range are underfunded. Local PE is focused on larger deals; international buyers are cautious about the NZ market size and exit complexity. If you're selling a NZD 2M EBITDA business, you're competing with 3–4 other similar vendors for a small buyer pool. Trade buyers (local operators or larger industry players) are usually the only realistic option, and they have pricing power. **AU mid-market is overheated**: Geographically diversified Australian businesses in hot sectors (healthcare, SaaS, logistics) face intense PE competition and shortening timelines. **Single-product or single-customer dependency kills valuation**: If 80%+ of revenue comes from one customer or product, expect a 1–1.5x EBITDA discount. Buyers see this as unacceptable concentration risk. **No documented systems = no buyer interest**: Businesses where operations depend on the founder carry enormous key-person risk. Buyers price this in heavily — multiples collapse to 3–4x regardless of revenue. This is fixable (see data visualisation on systemisation impact), but it requires 6–12 months of work before sale.

What to expect in H2 2026 and beyond

**Expected baseline**: Selective deal flow continues. PE capital flows to high-quality mid-market businesses (NZD 2M+ EBITDA, 20%+ growth, clear buyer universe). Trade buyers remain the best path for lower-tier and niche businesses. **Upside scenario**: If interest rates drop and equity markets strengthen, deal flow accelerates and multiples expand 0.5–1x. **Downside risk**: If interest rates spike or equity markets tumble, deal flow tightens, multiples compress 0.5–1.5x, and timelines extend to 12+ months. **Structural shift**: Earn-outs and vendor-financed deals will become more common as buyers hedge valuation risk. Sellers willing to take deferred consideration (base price at 70% plus 25–30% earn-out) are likely to get higher overall valuations and faster closings. **Implication for 2026 sellers**: Position your business now. Systemise if you haven't already. Build management depth. Lock in processes. Businesses that address these items in Q1–Q2 2026 will have maximum leverage in H2 when deal flow peaks and competition for quality assets increases.